Revolution Medicines, Inc. is 1.4x more valuable than BioNTech SE by market capitalization ($30.65 B vs $21.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RVMD | BNTX |
|---|---|---|
| Market cap | $30.65 B | $21.79 B |
| US-listed rank | #454 | #587 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$1.13B | - |
| SEC filings | 782 | 548 |
Revolution Medicines, Inc. is 1.4x more valuable than BioNTech SE by market capitalization ($30.65 B vs $21.79 B).
Full pages: Revolution Medicines, Inc. and BioNTech SE, or browse the full rankings.